Connect with us

Press Releases

Envision Research Institute Appoints Dr. Jeremy Barton to Advance Research in Mobile Telemedicine for Low Vision

 With a doctoral background in Applied Physics and extensive research contributions on human disease, Dr. Barton’s expertise will be invaluable to ERI’s research framework.




(PRESS RELEASE) The Gigi and Carl Allen Envision Research Institute (ERI) formally announces Dr. Jeremy Barton as a new Research Fellow. With a doctoral background in Applied Physics and extensive research contributions on human disease, Dr. Barton’s expertise will be invaluable to ERI’s research framework. His tenure, financed by the Lucier Family Fund, will primarily focus on the analytical evaluation of a novel mobile telemedicine device.

Michael Monteferrante, Envision President and CEO, stated, “ERI is committed to impactive and rigorous research aimed at removing barriers and challenging the status quo of what is possible in the daily lives of those who are blind or visually impaired. Dr. Barton’s inclusion will further bolster our research capabilities and potential outcomes.”

Dr. Barton’s research trajectory will center on an emergent tool designed for ophthalmological and optometrically diagnostics. This tool, while still in the developmental phase, will provide an efficient mechanism for physicians to obtain diagnostic images of the inner eye from geographically remote or atypical locations.

Dr. Barton, who has been visually impaired since birth, commented on his appointment, “It is an honor to collaborate with the Envision Research Institute. The institute’s ongoing interdisciplinary endeavors to fill gaps within the low vision technology industry are commendable and hold profound implications for countless individuals, myself included. I anticipate making meaningful contributions to this scholarly discourse.”

Highlighting the importance of the research, Greg Lucier, trustee of the Lucier Family Fund, remarked, “The preservation and enhancement of vision are critical aspects of human well-being. The Lucier Family Fund remains dedicated to supporting research and innovations with partners like Envision and Dr. Barton.”

Established in 2013, ERI has been a nexus for systematic investigation in the fields of low vision and blind rehabilitation, attracting international scholars. The institution’s objectives encompass elevating standards for patient care in visual impairment, facilitating early detection and treatment access, refining rehabilitation methodologies, and spearheading advancements in accessibility technology. ERI’s postdoctoral fellowships provide an academic setting wherein appointees conduct research to address the challenges faced by people who are blind or visually impaired.


Additional details about ERI and its Postdoctoral Fellowship program can be found



The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines






Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular